Todd Harris: CEO of Tyra Biosciences

Portrait of Todd Harris

Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.

Alexion Pharmaceuticals

Rare Heroes

Psivant Employees in front of monitor with molecular model.
Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom

Danbury Hospital Annual Report Cover
Danbury Hospital

A Prescription for the Future